U.S. Markets closed

Alexion Pharmaceuticals, Inc. (ALXN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
120.51-0.55 (-0.45%)
At close: 4:00PM EST

120.51 0.00 (0.00%)
After hours: 5:33PM EST

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3128.57
52 Week Low 372.67
50-Day Moving Average 3122.35
200-Day Moving Average 3113.30

Share Statistics

Avg Vol (3 month) 31.93M
Avg Vol (10 day) 31.06M
Shares Outstanding 5218.84M
Float 218.23M
% Held by Insiders 10.22%
% Held by Institutions 193.50%
Shares Short (Nov 12, 2020) 44.12M
Short Ratio (Nov 12, 2020) 42.6
Short % of Float (Nov 12, 2020) 41.96%
Short % of Shares Outstanding (Nov 12, 2020) 41.88%
Shares Short (prior month Oct 14, 2020) 45.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3May 22, 2011

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 16.32%
Operating Margin (ttm)47.42%

Management Effectiveness

Return on Assets (ttm)10.74%
Return on Equity (ttm)8.92%

Income Statement

Revenue (ttm)5.86B
Revenue Per Share (ttm)26.57
Quarterly Revenue Growth (yoy)25.80%
Gross Profit (ttm)4.6B
EBITDA 3.1B
Net Income Avi to Common (ttm)956.6M
Diluted EPS (ttm)4.31
Quarterly Earnings Growth (yoy)23.60%

Balance Sheet

Total Cash (mrq)2.3B
Total Cash Per Share (mrq)10.5
Total Debt (mrq)2.97B
Total Debt/Equity (mrq)26.82
Current Ratio (mrq)3.81
Book Value Per Share (mrq)50.57

Cash Flow Statement

Operating Cash Flow (ttm)2.68B
Levered Free Cash Flow (ttm)1.79B